Supernus SUPN
NASDAQ SUPN
$29.11 +0.36 (+1.25%)
As of: Nov 11, 2026 · 10:44 AM EST

Supernus (SUPN) Net Equity Issued and Repurchased (2022 - 2026)

Updated

Supernus Pharmaceuticals' Net Equity Issued and Repurchased came in at $2.34 million for Q3 2026, down 90.2% from $23.74 million a year earlier and down 43.4% from the prior quarter.

Analysis

Supernus (SUPN) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Supernus Pharmaceuticals reported Net Equity Issued and Repurchased of $28.69 million, down 20.2% year-over-year; for FY2025, it was $37.62 million, up 152.3% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 53.9% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $14.91 million in FY2024 (+125.5%), $6.61 million in FY2023 (-46.8%), $12.42 million in FY2022 (+75.1%) and $7.1 million in FY2021 (+62.7%).
  • The Q3 2026 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q1 2025.
  • Year-over-year, Net Equity Issued and Repurchased increased in six of the last eight quarters, with growth averaging 214.1%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q3 2025 (growth of 585.8%), and the weakest in Q3 2026 (a decline of 90.2%).
  • Business Quant data shows SUPN's Net Equity Issued and Repurchased at $4.12 million (Q2 2026), $13.67 million (Q1 2026) and $8.56 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Supernus 3.39 Bn 2.50 Bn 305.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -177.00 Mn
Mar 31, 2026 -125.00 Mn
Sep 30, 2025 1.00 Mn
Mar 31, 2025 -10.00 Mn
Dec 31, 2024 -50.00 Mn
Sep 30, 2024 -51.00 Mn
Jun 30, 2024 -35.00 Mn
Mar 31, 2024 -34.00 Mn
Dec 31, 2023 -45.00 Mn
Sep 30, 2023 2.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 -156.00 Mn
Sep 30, 2022 37.00 Mn
API Access

Supernus Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SUPN&period=max&api_key=YOUR_API_KEY